Results 161 to 170 of about 1,381,406 (265)

Global, regional, and national burden of pulmonary arterial hypertension, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

Summary Background: Pulmonary arterial hypertension (PAH) is a vascular disease characterised by restricted flow and high pressure through the pulmonary arteries, leading to progressive right heart failure and death. This study reports the global burden
GBD 2021 Pulmonary Arterial Hypertension Collaborators
core   +1 more source

Commonalities of platelet dysfunction in heart failure with preserved ejection fraction and underlying comorbidities

ESC Heart Failure, Volume 12, Issue 2, Page 1013-1028, April 2025.
Abstract Heart failure with preserved ejection fraction (HFpEF) is characterized by a lack of a specific targeted treatment and a complex, partially unexplored pathophysiology. Common comorbidities associated with HFpEF are hypertension, atrial fibrillation, obesity and diabetes.
Giorgia D'Italia, Blanche Schroen, Judith M.E.M. Cosemans   +2 more
wiley   +1 more source

2014 Guidelines of Taiwan Society of Cardiology (TSOC) for the Management of Pulmonary Arterial Hypertension

, 2017
Pulmonary hypertension (PH) is a hemodynamic and pathophysiologic condition, defined as a.,mean pulmonary arterial pressure exceeding 25 mmHg at rest.
Hsu, Chih-Hsin;Ho, Wan-Ling;Huang, Wei-Chun;Chiu, Yu-Wei;Hsu, Tsu-Shiu;Kuo, Ping-Hung;Hsu, Hsao-Hsun;Chang, Jia-Kan;Cheng, Chin-Chang;Lai, Chao-Lun;Liang, Kae-Woei;Lin, Shoa-Lin;Sung, Shih-Hsien;Tsai, Wei-Chuan;Weng, Ken-Pen;Hsieh, Kai-Sheng;Yin, Wei-Hsian;Lin, Shing-Jong;Wang, Kuo-Yang, 賴超倫;郭炳宏;徐紹勛   +1 more
core  

Cardiac remodelling in the era of the recommended four pillars heart failure medical therapy

ESC Heart Failure, Volume 12, Issue 2, Page 1029-1044, April 2025.
Abstract Cardiac remodelling is a key determinant of worse cardiovascular outcome in patients with heart failure (HF) and reduced ejection fraction (HFrEF). It affects both the left ventricle (LV) structure and function as well as the left atrium (LA) and the right ventricle (RV).
Giada Colombo, Tor Biering‐Sorensen, Joao P. Ferreira, Carlo Mario Lombardi, Andrea Bonelli, Andrea Garascia, Marco Metra, Riccardo M. Inciardi   +7 more
wiley   +1 more source

Exploring the Lung-Liver Axis in Pulmonary Arterial Hypertension. [PDF]

Compr Physiol
Singh N, Lawson J, Ragavendran A, Banerjee S, Hon A, Vega A, Hong J, Mullin CJ, Pereira M, Sherman-Roe A, Jorrin AT, Cayton T, Fishbein G, Klinger JR, Oldham WM, Wang RS, Dai Z, Fallon M, Harrington EO, Liang OD, Umar S, Ventetuolo CE.   +21 more
europepmc   +1 more source

Left ventricular function improvement during angiotensin receptor–neprilysin inhibitor treatment in a cohort of HFrEF/HFmrEF patients

ESC Heart Failure, Volume 12, Issue 2, Page 1151-1165, April 2025.
Prediction of LVEF improvement in patients with HFrEF and HFmrEF following treatment with Sacubitril/Valsartan. Workflow of this study investigating the functional capacity improvement in response to Sacubitrail/Valsartsan in a real‐world scenario of heart failure treatment.
Florian Appenzeller, Tobias Harm, Manuel Sigle, Parwez Aidery, Klaus‐Peter Kreisselmeier, Livia Baas, Andreas Goldschmied, Meinrad Paul Gawaz, Karin Anne Lydia Müller   +8 more
wiley   +1 more source

Poverty and Social Deprivation in Patients With Pulmonary Arterial Hypertension-A PHAR Analysis. [PDF]

Pulm Circ
Bernardo RJ, Lu D, Hedlin H, Grinnan D, Machado RF, Melendres-Groves L, Elwing JM, Sahay S, Kawut SM, Robinson JC, de Jesus Perez VA, Zamanian RT, PHAR Investigators.   +12 more
europepmc   +1 more source

The effects of sodium–glucose cotransporter 2 inhibitors on the ‘forgotten’ right ventricle

ESC Heart Failure, Volume 12, Issue 2, Page 1045-1058, April 2025.
Abstract With the progress in diagnosis, treatment and imaging techniques, there is a growing recognition that impaired right ventricular (RV) function profoundly affects the prognosis of patients with heart failure (HF), irrespective of their left ventricular ejection fraction (LVEF).
Liangzhen Qu, Xueting Duan, Han Chen
wiley   +1 more source

Haemodynamic partial remission as a prognostic target in pulmonary arterial hypertension. [PDF]

ERJ Open Res
Cruz-Utrilla A, Martín De Miguel I, Gutiérrez Ortiz E, Jiménez López-Guarch C, Velázquez M, Segura De la Cal T, Sarnago F, Maneiro Melón N, Brown Arreola B, Ochoa Parra N, Juan Arévalo Y, Arribas Ynsaurriaga F, Escribano-Subias P.   +12 more
europepmc   +1 more source

Interventional therapies for chronic heart failure: An overview of recent developments

ESC Heart Failure, Volume 12, Issue 2, Page 1081-1094, April 2025.
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo, Si Shi, Yutong Guo, Jie Xiong, Bo Wang, Zengxiang Dong, Dianyu Gao, Yingfeng Tu   +7 more
wiley   +1 more source